|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online September 19, 2008
Journal of Experimental Biology 211, 3195-3204 (2008)
Published by The Company of Biologists 2008
doi: 10.1242/jeb.019968
Systematic differences in membrane acyl composition associated with varying body mass in mammals occur in all phospholipid classes: an analysis of kidney and brain
1 Metabolic Research Centre, University of Wollongong, Wollongong, New South
Wales, Australia 2522
2 School of Health Sciences, University of Wollongong, Wollongong, New South
Wales, Australia 2522
3 School of Chemistry, University of Wollongong, Wollongong, New South Wales,
Australia 2522
* Author for correspondence (e-mail: pelse{at}uow.edu.au)
Accepted 17 July 2008
| Summary |
|---|
|
|
|---|
91% and
88% of
all phospholipids in kidney and brain, respectively. The lack of sphingomyelin
in the mouse tissues and higher levels in larger mammals suggests an increased
presence of membrane lipid rafts in larger mammals. The results of this study
support the proposal that the physical properties of membranes are likely to
be involved in changing metabolic rate.
Key words: fatty acids, lipids, lipid head group, metabolism, mass spectrometry, phospholipids, glycerophospholipids, lipid class, lipid rafts, ESI–MS, basal metabolic rate, lipidomics
| INTRODUCTION |
|---|
|
|
|---|
The measurement of membrane phospholipid acyl composition in these previous
experiments has been conducted using gas chromatography following hydrolysis
of fatty acids from their glycerol backbone. This utilitarian method has one
major disadvantage; it cannot identify the phospholipid class(es) within which
this variation occurs. To gain this information requires a multidimensional
chromatography approach that can reduce the sensitivity and reliability of the
measurement. An alternative method for analysis of intact phospholipids is
electrospray ionisation tandem mass spectrometry. The appeal of mass
spectrometry is its ability to provide accurate, reliable, unambiguous
identification and quantification of intact phospholipid molecules with high
sensitivity (Ekroos et al.,
2002
; Han and Gross,
2003
; Han and Gross,
2005
; Pulfer and Murphy,
2003
).
Recently we applied this new approach to examine the membrane lipids of a
mammal (the rat, Rattus norvegicus) and a reptile (a lizard,
Trachydosaurus rugosus) of similar body mass and preferred body
temperature. The study (Mitchell et al.,
2007
) examined the molecular sources of the lower unsaturation
index (the number of double bonds per 100 acyl chains), higher
monounsaturation and lower polyunsaturation of membrane phospholipids
previously described in ectothermic compared with endothermic vertebrates
(Hulbert and Else, 1989
). The
study (Mitchell et al., 2007
)
found that all phospholipid classes contribute to the differences in acyl
composition of membrane phospholipids and that the distribution of
phospholipid classes within the same tissues of the mammal and reptile were
essentially the same.
In this present study we used a similar method to examine the phospholipids
responsible for the systematic differences in acyl composition reported for
mammals of different body size (Hulbert et
al., 2002b
). These differences include decreases in the
unsaturation index and decreases in the omega-3 (n-3) polyunsaturated fat
content (particularly docosahexaenoic acid 22:6n-3) with increasing body mass
in mammals. Kidney and brain were chosen as the tissues for examination based
on their apparent differences in mammals
(Hulbert et al., 2002b
). In
kidney, membrane acyl composition has been found to vary with variation in
body size, in line with that found in other tissues (e.g. liver, heart and
skeletal muscle) and its dominant polyunsaturated fats are omega-6 (n-6) fats.
By contrast, the brain does not show these large-scale changes in membrane
acyl composition with changes in body mass, and its dominant polyunsaturated
fats are omega-3 fats (Hulbert et al.,
2002b
).
Species selection for this study was based on those mammals most commonly
used in body size (allometric) analysis and ready availability. It should be
noted that because of the large volume of work involved in these measurements
we were forced to limit our species selection to three mammal species only
(i.e. mouse, sheep and cow). The previous results for the rat were not
included since although similar, the methods employed were subtly different
and so did not allow for reliable quantitative comparison. Furthermore, it
should be noted that this study is not an allometric study nor has it the
capacity to avoid some phylogenetic bias based on the number of species used.
The animals used in the current study have already been shown to reflect the
average membrane phospholipid acyl composition for body mass in mammals
(Hulbert et al., 2002b
). This
study focuses on examining membrane phospholipid molecules in precise detail
in three different-sized mammal species against the differences in acyl
composition already well established for mammals and well represented by the
mammals chosen for inclusion in this study
(Hulbert et al., 2002b
).
Based on our study of an ectotherm and endotherm, we hypothesized that the same rules would apply to differences in phospholipid acyl composition in mammals of varying body mass. We proposed that changes in acyl composition such as the reduction in unsaturation index and decrease in the more highly unsaturated omega-3 and omega-6 fats with increase in mass in mammals will be spread throughout all phospholipid classes and that phospholipid head group (i.e. class) will be regulated and similar in the different-sized mammals.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Animals, organs and ethics
Sheep (Ovis aries L.; body mass
38 kg) and cattle (Bos
taurus L.; herein referred to as cow, body mass
560 kg) kidney and
brains were collected from the Wollondilly Abattoir (Picton, NSW, Australia)
immediately following the death of each animal. Organs were transported on ice
then stored at –80°C until used. Body masses for the sheep and
cattle were determined from their individual carcass mass (i.e. that of
slaughtered animal minus hide, head, tail, extremities and viscera) assumed to
be 55% of body mass (as determined and used commercially at the abattoir).
Male C57bl/6 mice (Mus musculus Linnaeus; body mass
30 g) were
obtained from the Animal Resource Centre (Perth, WA, Australia), kept under
standard 12 h:12 h light:dark conditions and sacrificed by peritoneal
injection of sodium pentobarbitone at a concentration of 0.6 mg
g–1 body mass. The kidney and brains were collected from four
individuals of the three animal species studied and stored at –80°C
until used. The University of Wollongong Animal Ethics Committee approved all
animal-based experimentation.
Lipid extraction
Samples of brain and kidney were homogenised (at 0.25 g
ml–1) in glass–glass tissue homogenisers in 2:1
chloroform:methanol containing 0.01% butylated hydroxytoluene and 4
µlmg–1 tissue of a stock solution of phospholipid internal
standards [phosphatidylcholine (PC) 19:0/19:0, 250 µmol
l–1; phosphatidylethanolamine (PE) 17:0/17:0, 188 µmol
l–1; phosphatidylserine (PS) 17:0/17:0, 125 µmol
l–1; phosphatidic acid (PA) 17:0/17:0, 25 µmol
l–1; and phosphatidylglycerol (PG) 17:0/17:0, 25 µmol
l–1, in methanol:chloroform) was added. Total lipid extracts
were then place on a rotating platform that turned the samples upside down
overnight in order to maximise lipid extraction. This was followed by an acid
wash (1 mol l–1 H2SO4) to further
enhance extraction of acidic phospholipids and standard procedures followed
thereafter as previously described (Folch
et al., 1957
). All extracts were stored at –80°C until
analysed.
Mass spectrometry
Electrospray ionisation mass spectrometry (ESI–MS) analysis was
performed on a Waters QuattroMicroTM (Waters, Manchester, UK) equipped
with a z-spray electrospray ion source and controlled by Micromass Masslynx
version 4.0 software. Capillary voltage was set to 3000 V, source temperature
80°C and desolvation temperature 120°C. Cone voltage was set to 50 V
and –35 V in negative and positive ion mode, respectively. Nitrogen was
used as the drying gas at a flow rate of 320 l h–1.
Phospholipid extracts were diluted to an estimated final concentration of 40
µmol l–1 with the addition of methanol:chloroform (2:1
v:v). For negative ion analyses, ammonia (28%) was added to adjust the pH to
10. Samples were infused into the electrospray ion source at a flow rate of 10
µl min–1 using the instrument's on-board syringe pump. In
all precursor ion, neutral loss and product ion scans, argon was used as the
collision gas at a pressure of 3 mTorr and the collision energy was set
between 22–50 eV depending upon on the scan being performed.
Phosphatidic acid (PA), phosphatidylglycerol (PG), phosphatidylinositol (PI),
phosphatidylethanolamine (PE) and phosphatidylserine (PS) phospholipids
readily form [M–H]– anions in negative ion mode and
were detected in the mass range of m/z 640–940. By contrast
phosphatidylcholine (PC) and sphingomyelin (SM) phospholipids were detected as
[M+H]+ ions in positive ion mode at m/z 640–850
(Brugger et al., 1997
). PE and
PS phospholipids also formed abundant [M+H]+ ions in positive ion
mode that were used here for quantification of these two classes. Overall a
combination of precursor ion and neutral loss scans in both positive and
negative ion modes were used to identify the head-group of each phospholipid
as previously described. For phospholipid classes observed in negative ion
mode, precursor ion scans of the fatty acid carboxylate anions in negative ion
mode allowed for the identification of fatty acids associated with each
individual phospholipid. To allow for the identification of the acyl chains in
PC phospholipids, neutral loss scans for loss of the lithiated fatty acids
were performed in positive ion mode after aqueous lithium acetate was added to
the lipid extract (to a final concentration of 200 µmol
l–1 in methanol:chloroform 2:1; v:v). A full description of
all scans types performed in this study and corresponding instrumental
parameters is provided in Table S1 in supplementary material. Where two or
more isomeric phospholipids of the same class were identified (e.g.
PE18:1/18:1 and PE18:0/18:2) a product ion spectrum was obtained. The
abundances of the pairs of fatty acid carboxylate anions arising from each
isomer in this spectrum were summed and normalized to the abundance of all
fatty acid carboxylate anions to obtain the relative contribution of all
isomers to the abundance of the parent ion (e.g. the contribution of PE
18:0/18:2 to the precursor ion at m/z 742 is given by the correction
factor
[I283+I279]/[I283+I279+I281],
where I283, I281 and
I279 are the intensities of the 18:0, 18:1 and 18:2 fatty
acid carboxylate anions, respectively, in the product ion spectrum of
m/z 742 in negative ion mode). It should be noted that neither the
relative position of the acyl chains on the glycerol backbone (sometimes
called the sn-position) (Ekroos et
al., 2003
) nor the position of double bonds
(Thomas et al., 2007
) can be
rigorously assigned from these data and discussions in this paper are based on
naturally abundant regioisomers.
For quantification purposes, head-group-specific neutral loss and precursor
ion mass spectra (see Table S1 in supplementary material) were obtained from
averaging a minimum of 200 scans. Phospholipids were quantified by comparing
their peak areas with the peak area of an appropriate internal standard for
each phospholipid class following corrections for isotope contributions as
described by Han and Gross (Han and Gross,
2005
). Briefly, the increasing natural abundance of
13C-isotope ions with increasing carbon chain length distributes
the ion abundance from a single phospholipid toward isotopologues of higher
mass. For accurate quantification, the contributions of all isotopologues were
summed to provide a single, comparable measure of abundance for each lipid;
independent of size. To achieve this, the isotopic ion distribution of each
phospholipid was calculated from isotope models and the area of the
monoisotopic peak was multiplied by the calculated correction factor. For
example, the calculated isotopic abundances for PE 18:2/18:2 are M=1.0,
M+1=0.475, M+2=0.126 and M+3=0.024 and thus for quantification, the abundance
of the monoisotopic ion is corrected by a factor of 1.63. Conversely, the
contribution of phospholipid isotopologues to the area of the monoisotopic
peak of a lipid of higher m/z needs to be subtracted for accurate
quantification. Isotopic corrections of this type were carried out
sequentially from low to high m/z such that any contribution of
isotopologues from low mass lipids were subtracted from phospholipids of
greater m/z, prior to isotopic correction of the abundance of the
heavier ion (as above). For example, if both PE 18:2/18:2 and PE 18:1/18:2
were found to be present in a positive ion mass spectrum, the abundance of the
latter lipid (APE 18:1/18:2) was obtained from the corrected
intensity of the peak at m/z 742 (I742) via
APE 18:1/18:2=I742–0.126xAPE
18:2/18:2, where APE 18:2/18:2 is the already corrected abundance of
PE 18:2/18:2.
As no appropriate internal standards for SM or PI where available, their
concentrations where derived from internal standards from related lipid
classes. Specifically, sphingomyelins were quantified by comparison with the
PC internal standard and multiplication by a correction factor of 3.15 that
takes into account the underestimation of SM abundance in precursor ion scans
of m/z 184 due to the differing fragmentation efficiency of these two
choline-bearing lipid classes. The correction factor was determined by
comparison of signal response of SM 16:0 and SM 18:1 with PC 16:0/18:1 and PC
18:1/18:1 in m/z 184 precursor ion scans over a concentration range
of 0.8–1.6 µmol l–1. An approximate quantification
of PI was achieved via comparison of the most abundant
phosphatidylinositol, PI 18:0/20:4, to the mean abundance of PA and PG
internal standards in a negative ion mass spectrum. This empirical correction
for relative ionization efficiencies is derived from Koivusalo et al.
(Koivusalo et al., 2001
). The
relative abundance of other PIs were then derived by comparison with PI
18:0/20:4 in an m/z 241 precursor ion scan undertaken in negative ion
mode. Given the approximations associated with the quantification of both SM
and PI, these data are treated separately to those of other phospholipid
classes in the following discussion.
Statistical analysis
Data were analysed by a one-way ANOVA using species as a fixed factor, with
a Student's t-test for comparison of means. For unequal variances, a
Welch one-way ANOVA was undertaken. Normality of data was assumed from
previous GC studies (Hulbert et al.,
2002b
). P values of <0.05 were considered
statistically significant, and all values are expressed as means ±
s.e.m. Statistical analyses were completed using JMP 5.1 (SAS Institute, NC,
USA).
| RESULTS |
|---|
|
|
|---|
|
|
|
|
Among kidney PE phospholipids, the molecule with the highest concentration in all three mammalian species was PE 18:0/20:4. The only other PE molecule present in moderately high abundance (in all three species) was PE 18:1/20.4. The PS phospholipids in highest concentration in both the mouse and sheep was PS 18:0/20:4, whereas in the cow PS 18:0/18:2 was most abundant, followed by PS 18:0/20:4. Among the other phospholipid classes there were no common trends with the most common PA molecule being PA 18:0/20:4 in the mouse, PA 16:0/18:1 in the sheep and PA 16:0/18:2 in the cow. In mouse kidney, 24 different molecular combinations of PA were detected whereas the variety of PA molecules in the sheep and cow was almost half that amount (11 and 14 PA molecules, respectively). This probably reflects a higher and therefore more detectable level of PA molecules in the mouse kidney. For PG the only detectable molecule was PG 16:0/18:1 and this was only found in sheep and cow kidney. SMs were not detected in the mouse kidney but were detected in both the sheep and cow kidney with the same nine SM combinations found: SM 16:0 was found at several times higher concentration (2.7 and 2.1 µmol g–1 tissue) than other SMs. Of the SMs present in both the sheep and cow kidney, 80–85% contained a saturated fatty acid (mainly 16:0 or 22:0).
Brain
PC 16:0/18:1 constituting 24, 31 and 32% of all glycero phospholipids in
the brains of the mouse, sheep and cow, respectively, must be considered as
the primary `house keeping' phospholipid of the brain, being at levels two to
four times higher than the next most abundant PC molecule (PC 16:0/16:0). Most
PC phospholipid molecules in the brain were partnered with 16:0 (80–82%,
as also found for kidney). Among the 18:0-containing PC phospholipids,
18:0/18:1, 18:0/20:4 and 18:0/22:6 were present in relatively high abundance
in all three mammals. The high level of PC 18:0/18:1 in the brain was a
property not shared by the kidney. Other interesting PC phospholipids present
in higher concentrations in the brain of all three mammals were 16:0/22:6 and
16:0/20:4 that shared similar levels in the brain (
2.4–5% of PC
molecules).
Among brain PE molecules, PE 18:0/22:6 was the most abundant being 2–5 times more concentrated than the next most abundant molecules PE 18:0/20:4 and PE16:0/22:6. PE molecules were highly polyunsaturated (80–87% of molecules). Although PE molecules represented only 18–21% of brain glycerophospholipids they served as the major source of polyunsaturated fats raising the unsaturation index (i.e. the number of double bonds per 100 acyl chains) from 83, 76 and 68 without PE to 144, 138 and 128 with PE in mouse, sheep and cow brain, respectively. PS 18:0/22:6 was the most common phosphatidylserine molecule and the major contributor to membrane docosahexaenoic acid (DHA) concentration. Among PA and PG molecules, PA 18:0/22:6 and PG 16:0/18:1 were the best represented, being present in all three animal species at low levels.
Contribution of individual glycerophospholipid molecules and phospholipid classes to the unsaturation index
The glycerophospholipids that contributed most to the unsaturation index
(UI) of the kidney were PC 16:0/22:6 (27.0) in mouse and PC 16:0/18:2 (9.8 and
19.7) in the sheep and cow (see Table
2). Owing to the higher UI in the mouse kidney, other major
contributors to UI in this species included PC16:0/20:4 (19.4), PE18:0/20:4
(16.2) and PC 18:0/20:4 (15.1) all contributing more than 15 UI units. In
sheep and cow kidneys the only other phospholipid that contributed
significantly to the UI was PE 18:0/20:4 (at 9.6 and 10.2, respectively). In
the brain the major contributors to UI were PE 18:0/22:6, PS18:0/22.6,
PC16:0/18:1 and PC16:0/22:6, in all three species.
Tables 3 and 4 compare the contributions of the four major phospholipid classes (PC, PE, PS and PA) to the UI of the kidney and brain of mouse, sheep and cow. The tables also show the contributions to UI of the primary unsaturated acyl chains (18:1n-9, 18:2n-6, 20:4n-6 and 22:6n-3) plus the sum of saturated, monounsaturated, omega-3 and omega-6 polyunsaturated fats within each class of phospholipid in the kidney and the brain of the three mammals. For kidney, UI decreases as body mass increases in all four classes of phospholipid (Table 3). In the brain the decrease in UI with increasing body mass only holds for PC and the change is small (but significant, because of the very low variance present in the values; see Table 4). In kidney, all four phospholipid classes examined showed relatively similar UI level in all three species. In brain, the UI of PE and PS was high (compared with PC and PA), primarily due to high docosahexaenoic acid (22:6n-3) levels and were the major contributors to the overall UI of the tissue. The major contributor to the UI in the kidney (in all four phospholipid classes) was arachidonic acid, in brain it was docosahexaenoic acid, emphasising the omega-6 and omega-3 dominance of kidney and brain, respectively.
|
|
Body mass variation and phospholipid molecules
As shown in Fig. 1 and
Fig. 2 many of the
glycerophospholipids show body mass trends. In kidney, the major PC molecules,
16:0/18:1 and PC 16:0/18:2, both increased with increasing body mass whereas
PC 16:0/22:6, 16:0/20:4 and 18:0/20:4 each with a long, highly unsaturated
acyl chain tended to decrease in concentration with increasing body mass. The
reduction in arachidonic acid (20:4n-6) with increasing body mass in PC of
kidney, however, did not cause a fall in the overall omega-6 content of the PC
lipids since the shorter-chained, less unsaturated linoleic acid made up the
difference, with increasing concentrations of PC 16:0/18:2. The main PE and PS
molecules in the kidney also showed some body mass changes with molecular
combinations, with monounsaturates (18:1) and linoleic acid (18:2) increasing
(e.g. PE 16:0/18:1, 18:1/18:1, 16:0/18:2 and 18:1/18:2 and PS 16:0/18:2 and
18:0/18:2) with body mass and those molecules with long, highly unsaturated
acyl chains (20:4 and 22:6) decreasing (e.g. PE 16:0/22:6, 18:0/22:6 and
18:1/22:6 and PS 16:0/20:4, 18:0/20:4, 18:0/22:6; see
Fig. 1 and
Table 2 for statistical
analysis of phospholipid species). Basically, as mammals increased in body
mass the acyl chain of the kidney phospholipids became less unsaturated with
fewer phospholipid molecules containing 22:6 and 20:4 and more contained 18:1
and 18:2 (Fig. 1;
Table 3). Therefore, reductions
in unsaturation index (UI) were underpinned by mass-dependent changes in every
major phospholipid class.
In brain, there were fewer differences in the concentration of phospholipids, with those containing either arachidonic (20:4) or docosahexaenoic (22:6) acid being more similar between the species. There was a tendency for brain phospholipid molecules containing 18:1 to increase with body mass, notably among these was PC 16:0/18:1. Few brain phospholipid molecules contained linoleic acid (18:2) presumably as a result of it being converted to the longer chained arachidonic acid (20:4n-6). Few body mass trends seemed to be apparent in the brain with phospholipids displaying a more uniformed acyl phospholipid composition among the different-sized mammals.
| DISCUSSION |
|---|
|
|
|---|
91% and
88% of all glycerophospholipid molecules in the kidney and
brain, respectively, in the three mammal species. These values are comparable
to 88 and 86% of all glycerophospholipid molecules for PC and PE found in
kidney and brain of another mammal and a reptile previously examined
(Mitchell et al., 2007
Many different types of phospholipid molecules within each class of
phospholipid showed body-mass-related differences in their acyl composition.
These differences account for the previously described decrease in membrane
unsaturation associated with increasing body mass in mammalian species
measured using gas chromatography (Hulbert
et al., 2002b
). This body-mass-dependent decrease in membrane
unsaturation does not occur by decreases in the percentage of unsaturated acyl
chains but alternatively by alterations in the type of unsaturates present.
This includes increases in the use of monounsaturates (MUFA) and shorter, less
unsaturated molecules at the expense of long-chain omega-3 (n-3) and omega-6
(n-6) polyunsaturated (PUFA) fats. This substitution was clearly evident in
the kidney, with an increase in MUFA and a decrease in the long-chained,
highly unsaturated omega-3 and omega-6 PUFAs with increasing body mass. In
brain, the mass-dependent differences in phospholipid acyl composition were
far less pronounced (as indicated by the reduction in the number of
significant differences between the mammals) than in the kidney (see
Table 2), in agreement with the
previous work of Hulbert and colleagues
(Hulbert et al., 2002b
).
The domination of omega-6 in kidney and omega-3 in brain was found to be
spread throughout the phospholipid classes and was not restricted to any one
particular phospholipid class. In kidney all the PC molecules showed high
omega-6 PUFA content as a percentage of their overall fatty acid composition
(PC; 26–28%, PE; 34–39%, PS; 28–37%, PA; 25–48%).
However, the makeup of these omega-6 fats in kidney moved from primarily
arachidonic acid to linoleic acid in PC, PE and PS with increasing body mass.
The single largest contributor to the arachidonic acid content of kidney
membranes was PE 18:0/20:4, followed by PC 16:0/20:4, whereas the major
contributor to linoleic acid was PC 16:0/18:2 (see
Fig. 1). In the brain, the
omega-3 domination of PUFA was also found spread throughout all phospholipid
classes except PC, which had slightly more omega-6 than omega-3 in all three
mammals measured. In brain the dominant omega-3 acyl chain was the
long-chained docosahexaenoic acid (22:6n-3) with both PE18:0/22:6 and
PS18:0/22:6 being the major contributors (64–79%). The brain also
displayed less diversity of phospholipid molecules (64–66) compared with
the kidney (82–120; including all PC, PE, PS, PA, PG and SM molecules).
This greater phospholipid molecular diversity in the kidney was also found in
an analysis of tissues of an ectothermic lizard
(Mitchell et al., 2007
).
The measurement of the fatty acid acyl composition of kidney and brain
membrane glycerophospholipids by gas chromatography (GC) and mass spectrometry
(MS) showed some clear differences. These differences included higher
estimations for 16:0 and a lower estimation for 20:4n-6 and sometimes 22:6n-3
using MS than using GC (Table
5). These differences were also found in a previous study
(Mitchell et al., 2007
) and
points to the trend for a lower estimation of unsaturation index using MS
versus GC (in the kidney) primarily due to the effect of 20:4n-6 and 22:6n-6
upon UI.
|
The present study also found a lack of sphingomyelin phospholipids in both
the kidney and brain of the mouse, a condition not apparent in tissues of the
large mammal species. In sheep and cow, nine different types of sphingomyelin
molecules were detected in the kidney and five in the brain, with the major
molecules in both tissues being SM16:0 and SM18:0, respectively. Since lipid
rafts/caveolae structures are primarily composed of sphingomyelin and
cholesterol (Simons and Vaz,
2004
; Slotte and Ramstedt,
2007
) and the cholesterol to phospholipid ratio is similar in
different-sized mammals (Starke-Peterkovic
et al., 2005
) it seems likely that the composition of these lipid
structures varies with body mass, with the cholesterol to sphingomyelin ratio
decreasing with increasing body mass in mammals. Sphingomyelin molecules,
however, have been reported to be present in other mouse tissues, including
mouse lens tissues, at up to 20% of total phospholipids
[(Iwata et al., 1995
);
although lens tissue is known to have an extraordinarily high level of this
particular phospholipid (Slotte and
Ramstedt, 2007
)]. These results suggest that the tissues of larger
mammals may possess higher concentration or bigger raft structures. The
potential functional implications of this finding and the involvement of these
structures in modulating metabolism also remains an interesting unexplored
possibility.
The primary idea of the membrane pacemaker theory is that membrane lipids
provide an environment that can increase or decrease the activity of intrinsic
proteins. The activity of membrane bound enzymes, such as
Na+/K+-ATPase, is very different in mammals of different
body mass. In the mouse, Na+/K+-ATPase molecular
activities (turnover rate per enzyme) in the kidney and brain has been
calculated at 23,000 and 28,800 ATP min–1, respectively
(Turner et al., 2005a
;
Turner et al., 2005b
). In the
cow the molecular activities of the Na+/K+-ATPase in
kidney and brain is much lower at 6300 and 11,400 ATP min–1,
respectively (Starke-Peterkovic et al.,
2005
). These large differences in molecular activity have been
linked to differences in the acyl composition of the membrane phospholipids
including the level of membrane unsaturation and presence of long-chain highly
polyunsaturated fats, especially DHA
(Turner et al., 2003
). The
results of the present study suggest no single type of phospholipid molecule
or phospholipid class will be responsible for determining the membrane
properties associated with acyl composition between species since the
difference is spread across the full range of phospholipids.
Na+/K+-ATPase molecular activity has also been shown
to correlate more strongly with the lateral pressure of membrane lipid
mixtures than with the composition of any individual fatty acid in the
membrane (Wu et al., 2001
).
Na+/K+-ATPase appears to be distributed primarily in
non-raft domains of the cell membrane
(Atshaves et al., 2003
;
Gallegos et al., 2006
) and is
influenced by the transbilayer fluidity gradient
(Schroeder et al., 2005
;
Schroeder and Sweet, 1988
;
Sweet and Schroeder, 1986a
;
Sweet and Schroeder, 1986b
;
Sweet and Schroeder, 1988
).
This suggests that differences in molecular activity are likely to be
influenced by the physical properties of the bulk phase membrane lipids
created by the acyl composition of the phospholipids. This may be explained by
the fact that highly polyunsaturated fats have high level of dynamic motion
and flexibility since they have more bisallylic bonds (those that occur on
either side of the multiple double bonds present in highly polyunsaturated
molecules). This can create high lateral pressures in the immediate
environment of these acyl chains that may impinge upon the properties of
neighbouring proteins and other lipids in the membrane
(Carrillo-Tripp and Feller,
2005
). In this case, the present study suggests that all classes
of phospholipids are likely to be involved in determining the physical
properties of the membrane and any associated change in metabolism.
In summary, this study shows that differences in membrane phospholipid acyl
composition associated with body mass in mammals are spread throughout the
different classes of phospholipids, and that phospholipid class distribution
is very similar in the same tissues of the different-sized mammals and is
likely to be a regulated property of membranes in vertebrates. Furthermore,
given that these same properties were found in a similar comparison in a
different mammal (rat) and an ectothermic vertebrate (lizard)
(Mitchell et al., 2007
) it
suggests that the physical properties of membranes may be an important
determinant of the rate of metabolism in animal species.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Atshaves, B. P., Gallegos, A. M., McIntosh, A. L., Kier, A. B. and Schroeder, F. (2003). Sterol carrier protein-2 selectively alters lipid composition and cholesterol dynamics of caveolae/lipid raft vs non-raft domains in L-cell fibroblast plasma membranes. Biochemistry 42,14583 -14598.[CrossRef][Medline]
Brugger, B., Erben, G., Sandhoff, R., Wieland, F. T. and
Lehmann, W. D. (1997). Quantitative analysis of biological
membrane lipids at the low picomole level by nano-electrospray ionization
tandem mass spectrometry. Proc. Natl. Acad. Sci. USA
94,2339
-2344.
Carrillo-Tripp, M. and Feller, S. E. (2005). Evidence for a mechanism by which omega-3 polyunsaturated lipids may affect membrane protein function. Biochemistry 44,10164 -10169.[CrossRef][Medline]
Ekroos, K., Chernushevich, I. V., Simons, K. and Shevchenko, A. (2002). Quantitative profiling of phospholipids by multiple precursor ion scanning on a hybrid quadrupole time-of-flight mass spectrometer. Anal. Chem. 74,941 -949.[Medline]
Ekroos, K., Ejsing, C. S., Bahr, U., Karas, M., Simons, K. and
Shevchenko, A. (2003). Charting molecular composition of
phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation.
J. Lipid Res. 44,2181
-2192.
Else, P. L. and Wu, B. J. (1999). What role for membranes in determining the higher sodium pump molecular activity of mammals compared to ectotherms. J. Comp. Physiol. B 169,296 -302.[CrossRef][Medline]
Folch, J., Lees, M. and Sloane, S. G. H.
(1957). A simple method for the isolation and purification of
total lipides from animal tissues. J. Biol. Chem.
226,497
-509.
Gallegos, A. M., Storey, S. M., Kier, A. B., Schroeder, F. and Ball, J. M. (2006). Structure and cholesterol dynamics of caveolae/raft and non-raft plasma membrane domains. Biochemistry 45,12100 -12116.[CrossRef][Medline]
Han, X. and Gross, R. W. (2003). Global
analyses of cellular lipidomes directly from crude extracts of biological
samples by ESI mass spectrometry. J. Lipid Res.
44,1071
-1079.
Han, X. and Gross, R. W. (2005). Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes diurectly from crude extracts of biological samples. Mass Spectrom. Rev. 24,367 -412.[CrossRef][Medline]
Hulbert, A. J. and Else, P. L. (1989). The evolution of endothermic metabolism: mitochondrial activity and changes in cellular composition. Am. J. Physiol. 256,R1200 -R1208.[Medline]
Hulbert, A. J. and Else, P. L. (1999). Membranes as possible pacemakers of metabolism. J. Theor. Biol. 199,257 -274.[CrossRef][Medline]
Hulbert, A. J. and Else, P. L. (2000). Mechanisms underlying the cost of living in animals. Annu. Rev. Physiol. 62,207 -235.[CrossRef][Medline]
Hulbert, A. J., Faulks, S., Buttemer, W. A. and Else, P. L.
(2002a). Acyl composition of muscle membranes varies with body
size in birds. J. Exp. Biol.
205,3561
-3569.
Hulbert, A. J., Rana, T. and Couture, P. (2002b). The acyl composition of mammalian phospholipids: an allometric analysis. Comp. Biochem. Physiol. 132,515 -527.[CrossRef][Medline]
Iwata, J. L., Bardygula-Nonn, L. G., Glonek, T. and Greiner, J. V. (1995). Interspecies comparisons of lens phospholipids. Curr. Eye Res. 14,937 -941.[Medline]
Koivusalo, M., Hami, P., Heikinheimo, L., Kostiainen, R. and
Somerharju, P. (2001). Quantitative determination of
phospholipid compositions by ESI-MS: effects of acyl chain length,
unsaturation, and lipid concentration on instrument response. J.
Lipid Res. 42,663
-672.
Mitchell, T. W., Ekroos, K., Blanksby, S. J., Hulbert, A. J. and
Else, P. L. (2007). Differences in membrane acyl phosholipid
composition between an endothermic mammal and an ectothermic reptile are not
limited to any phospholipid class. J. Exp. Biol.
210,3440
-3450.
Pulfer, M. and Murphy, R. C. (2003). Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 22,332 -364.[CrossRef][Medline]
Schroeder, F. and Sweet, W. D. (1988). The role of membrane lipid and structure asymmetry on transport systems. In Advances in Biotechnology of Membrane Ion Transport (ed. P. L. Jorgensen and R. Verna), pp. 183-195. New York: Elsevier.
Schroeder, F., Atshaves, B. P., Gallegos, A. M., McIntosh, A. L., Kier, A. B., Huang, H. and Ball, J. M. (2005). Lipid rafts and caveolae organisation. In Advances in Molecular and Cellular Biology (ed. P. G. Frank and M. P. Lisanti), pp.3 -36. Amsterdam: Elsevier.
Simons, K. and Vaz, W. L. C. (2004). Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33,269 -295.[CrossRef][Medline]
Slotte, J. P. and Ramstedt, B. (2007). The functional role of sphingomyelin in cell membranes. Eur. J. Lipid Sci. Technol. 109,977 -981.[CrossRef]
Starke-Peterkovic, T., Turner, N., Else, P. L. and Clarke, R. J. (2005). Electrical field strength of membrane lipids from vertebrate species: membrane lipid composition and Na+,-K+-ATPase molecular activity. Am. J. Physiol. 288,R663 -R670.
Sweet, W. D. and Schroeder, F. (1986a). Charged anaesthetics alter LM-fibroblast plasma-membrane enzymes by selective fluidization of inner or outer membrane leaflets. Biochem. J. 239,301 -310.[Medline]
Sweet, W. D. and Schroeder, F. (1986b). Plasma membrane lipid composition modulates action of anaesthetics. Biochim. Biophys. Acta 861, 53-61.[Medline]
Sweet, W. D. and Schroeder, F. (1988). Lipid domains and enzyme activity. In Advances in Membrane Fluidity (ed. R. Aloia C. C. Cirtain and L. M. Gordon), pp.17 -42. New York: Alan R. Liss.
Thomas, M. C., Mitchell, T. W., Harman, D. G., Deeley, J. M., Murphy, R. C. and Blanksby, S. J. (2007). Elucidation of double bond position in unsaturated lipids by ozone electrospray ionization mass spectrometry (OzESI-MS). Anal. Chem. 79,5013 -5022.[Medline]
Turner, N., Hulbert, A. J. and Else, P. L. (2003). Docosahexaenoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease states and metabolism. Naturwissenschaften 90,521 -523.[CrossRef][Medline]
Turner, N., Else, P. L. and Hulbert, A. J.
(2005a). An allometric comparison of microsomal membrane lipid
composition and sodium pump molecular activity in the brain of mammals and
birds. J. Exp. Biol.
208,371
-381.
Turner, N., Haga, K. L., Hulbert, A. J. and Else, P. L. (2005b). Relationship between body size, Na+-K+-ATPase activity, and membrane lipid composition in mammal and bird kidney. Am. J. Physiol. 288,R301 -R310.
Wu, B. J., Else, P. L., Storlien, L. H. and Hulbert, A. J. (2001). Molecular activity of Na+/K+-ATPase from different sources is related to the packing of membrane lipids. J. Exp. Biol. 204,4271 -4280.[Medline]
Wu, B. J., Hulbert, A. J., Storlien, L. H. and Else, P. L. (2004). Membrane lipids and sodium pumps of cattle and crocodiles: An experimental test of the membrane pacemaker theory of metabolism. Am. J. Physiol. 287,R633 -R641.[CrossRef]
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||